Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Titel:
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Auteur:
Garcia, Jacqueline S. Kim, Haesook T. Murdock, H. Moses Cutler, Corey S. Brock, Jennifer Gooptu, Mahasweta Ho, Vincent T. Koreth, John Nikiforow, Sarah Romee, Rizwan Shapiro, Roman Loschi, Fiona Ryan, Jeremy Fell, Geoffrey Karp, Hannah Q. Lucas, Fabienne Kim, Annette S. Potter, Danielle Mashaka, Thelma Stone, Richard M. DeAngelo, Daniel J. Letai, Anthony Lindsley, R. Coleman Soiffer, Robert J. Antin, Joseph H.